"title" "geo_accession" "status" "submission_date" "last_update_date" "type" "channel_count" "source_name_ch1" "organism_ch1" "characteristics_ch1" "characteristics_ch1.1" "characteristics_ch1.2" "characteristics_ch1.3" "treatment_protocol_ch1" "growth_protocol_ch1" "molecule_ch1" "extract_protocol_ch1" "extract_protocol_ch1.1" "taxid_ch1" "data_processing" "data_processing.1" "data_processing.2" "platform_id" "contact_name" "contact_email" "contact_institute" "contact_address" "contact_city" "contact_zip.postal_code" "contact_country" "data_row_count" "instrument_model" "library_selection" "library_source" "library_strategy" "relation" "relation.1" "supplementary_file_1" "cell.line.ch1" "cell.type.ch1" "time..days..ch1" "treatment.ch1"
"GSM6777868" "corth2_S20" "GSM6777868" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: cort high3" "time (days): 3" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988944" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464630" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "3" "cort high3"
"GSM6777869" "corth3_S12" "GSM6777869" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: cort high3" "time (days): 3" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988943" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464631" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "3" "cort high3"
"GSM6777870" "corth4_S19" "GSM6777870" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: cort high3" "time (days): 3" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988942" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464632" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "3" "cort high3"
"GSM6777871" "corthwo2_S11" "GSM6777871" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: cort high6" "time (days): 6" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988941" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464633" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "6" "cort high6"
"GSM6777872" "corthwo3_S13" "GSM6777872" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: cort high6" "time (days): 6" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988940" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464634" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "6" "cort high6"
"GSM6777873" "corthwo4_S4" "GSM6777873" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: cort high6" "time (days): 6" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988939" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464635" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "6" "cort high6"
"GSM6777874" "cortl2_S14" "GSM6777874" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: cort low3" "time (days): 3" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988938" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464636" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "3" "cort low3"
"GSM6777875" "cortl3_S19" "GSM6777875" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: cort low3" "time (days): 3" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988937" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464637" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "3" "cort low3"
"GSM6777876" "cortl4_S13" "GSM6777876" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: cort low3" "time (days): 3" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988936" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464638" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "3" "cort low3"
"GSM6777877" "cortlwo2_S18" "GSM6777877" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: cort low6" "time (days): 6" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988935" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464639" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "6" "cort low6"
"GSM6777878" "cortlwo3_S6" "GSM6777878" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: cort low6" "time (days): 6" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988934" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464640" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "6" "cort low6"
"GSM6777879" "cortlwo4_S2" "GSM6777879" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: cort low6" "time (days): 6" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988933" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464641" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "6" "cort low6"
"GSM6777880" "Ctl1_S8" "GSM6777880" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: control3" "time (days): 3" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988932" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464642" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "3" "control3"
"GSM6777881" "ctl3_S10" "GSM6777881" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: control3" "time (days): 3" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988931" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464643" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "3" "control3"
"GSM6777882" "ctl4_S5" "GSM6777882" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: control3" "time (days): 3" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988930" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464644" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "3" "control3"
"GSM6777883" "cvh1_S21" "GSM6777883" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: cort vehicle high3" "time (days): 3" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988929" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464645" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "3" "cort vehicle high3"
"GSM6777884" "cvh2_S16" "GSM6777884" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: cort vehicle high3" "time (days): 3" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988928" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464659" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "3" "cort vehicle high3"
"GSM6777885" "cvh3_S14" "GSM6777885" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: cort vehicle high3" "time (days): 3" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988927" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464660" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "3" "cort vehicle high3"
"GSM6777886" "cvhwo1_S1" "GSM6777886" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: cort vehicle high6" "time (days): 6" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988926" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464661" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "6" "cort vehicle high6"
"GSM6777887" "cvl1_S18" "GSM6777887" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: cort vehicle low3" "time (days): 3" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988925" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464662" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "3" "cort vehicle low3"
"GSM6777888" "cvl2_S11" "GSM6777888" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: cort vehicle low3" "time (days): 3" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988924" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464663" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "3" "cort vehicle low3"
"GSM6777889" "cvl4_S7" "GSM6777889" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: cort vehicle low3" "time (days): 3" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988923" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464664" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "3" "cort vehicle low3"
"GSM6777890" "cvlwo2_S1" "GSM6777890" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: cort vehicle low6" "time (days): 6" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988922" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464665" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "6" "cort vehicle low6"
"GSM6777891" "dexh2_S15" "GSM6777891" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: dex high3" "time (days): 3" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988921" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464666" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "3" "dex high3"
"GSM6777892" "dexh3_S20" "GSM6777892" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: dex high3" "time (days): 3" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988920" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464667" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "3" "dex high3"
"GSM6777893" "dexh4_S7" "GSM6777893" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: dex high3" "time (days): 3" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988919" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464668" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "3" "dex high3"
"GSM6777894" "dexhwo2_S12" "GSM6777894" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: dex high6" "time (days): 6" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988918" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464669" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "6" "dex high6"
"GSM6777895" "dexhwo3_S17" "GSM6777895" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: dex high6" "time (days): 6" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988917" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464670" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "6" "dex high6"
"GSM6777896" "dexhwo4_S5" "GSM6777896" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: dex high6" "time (days): 6" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988916" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464671" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "6" "dex high6"
"GSM6777897" "dexl1_S16" "GSM6777897" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: dex low3" "time (days): 3" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988915" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464672" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "3" "dex low3"
"GSM6777898" "dexl2_S15" "GSM6777898" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: dex low3" "time (days): 3" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988914" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464646" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "3" "dex low3"
"GSM6777899" "dexl3_S9" "GSM6777899" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: dex low3" "time (days): 3" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988913" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464647" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "3" "dex low3"
"GSM6777900" "dexlwo1_S22" "GSM6777900" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: dex low6" "time (days): 6" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988912" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464648" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "6" "dex low6"
"GSM6777901" "dexlwo2_S3" "GSM6777901" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: dex low6" "time (days): 6" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988911" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464649" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "6" "dex low6"
"GSM6777902" "dexlwo3_S21" "GSM6777902" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: dex low6" "time (days): 6" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988910" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464650" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "6" "dex low6"
"GSM6777903" "dvh1_S4" "GSM6777903" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: dex vehicle high3" "time (days): 3" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988909" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464651" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "3" "dex vehicle high3"
"GSM6777904" "dvh2_S8" "GSM6777904" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: dex vehicle high3" "time (days): 3" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988908" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464652" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "3" "dex vehicle high3"
"GSM6777905" "dvh4_S10" "GSM6777905" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: dex vehicle high3" "time (days): 3" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988907" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464653" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "3" "dex vehicle high3"
"GSM6777906" "dvhwo4_S9" "GSM6777906" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: dex vehicle high6" "time (days): 6" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988906" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464654" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "6" "dex vehicle high6"
"GSM6777907" "dvl1_S3" "GSM6777907" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: dex vehicle low3" "time (days): 3" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988905" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464655" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "3" "dex vehicle low3"
"GSM6777908" "dvl2_S6" "GSM6777908" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: dex vehicle low3" "time (days): 3" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988904" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464656" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "3" "dex vehicle low3"
"GSM6777909" "dvl3_S2" "GSM6777909" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: dex vehicle low3" "time (days): 3" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988903" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464657" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "3" "dex vehicle low3"
"GSM6777910" "dvlwo3_S17" "GSM6777910" "Public on Dec 06 2022" "Dec 02 2022" "Dec 06 2022" "SRA" "1" "HMC3 (ATCC CRL-3304)" "Homo sapiens" "cell line: HMC3 (ATCC CRL-3304)" "cell type: microglial cell" "treatment: dex vehicle low6" "time (days): 6" "After 24 hours, the growth medium in each T-25 was replaced with media supplemented with one of the following treatments: dexamethasone (1 or 0.01 μM), hydrocortisone (10 or 0.01 μM), vehicle (ethanol alcohol) or control (untreated me- dia). Cells were incubated in treatment media for three days at 37àC and 5% CO2 and imaged daily using the Axio Vert.A1 inverted microscope (Zeiss Oberkochen, Germany). At three days post-exposure (D3), cells were collected from each flask individually, quantified on the Countess II cell counter (Invitrogen Waltham, MA), seeded at 2 x 105 viable cells/flask in new T-25 flasks with normal growth medium, and incubated for three additional days (i.e., washout period). The remaining D3 cell suspension for each flask was divided equally between two microcentrifuge tubes, pelleted and washed with PBS." "The microglial cell line HMC3 (ATCC CRL-3304, Manassas, Virginia) was used for in vitro experimentation following successful cell line authentication and My- coplasma testing (Genetica, Burlington, NC). HMC3 cells (passage eight) were seeded in T-25 flasks with 2 x 105 viable cells and incubated at 37àC and 5% CO2." "total RNA" "One cell pellet per flask was placed in -80C storage for future DNA extraction; the remaining cell pellet underwent RNA extraction using the RNeasy Mini Kit (QIAGEN, Hilden, Germany) protocol adapted for the QIAcube automated system (QIAGEN). On the final day of the washout period (D6), cells from each flask were imaged, collected in suspension and then quantified on the Countess II. Cell suspensions were split equally into two aliquots and then prepped for nucleic acid extraction as described for D3." "RNA samples from D3 and D6 were DNase treated (Dnase I kit; Sigma), quan- tified on the Qubit (RNA BR Assay Kit; Invitrogen) and scored for RNA integrity on the TapeStation (High Sensitivity RNA ScreenTape; Agilent, Santa Clara, CA). Library preparation was performed following the Illumina TruSeq Stranded Total RNA Library Prep Kit protocol (Illumina, San Diego, CA) with TruSeq RNA Sin- gle Indexes (Set A and B; Illumina). Library quantity and quality were assessed using the Qubit 1X dsDNA HS Assay (Invitrogen), TapeStation High Sensitiv- ity D1000 ScreenTape (Agilent) and the KAPA Library Quantification Kit (Roche Basel, Switzerland) for the LightCycler 96 (Roche). RNA sequencing was conducted on the NextSeq 550using the High Output Kit with 76 paired-end cycles (Illumina)." "9606" "Quality control was performed on fastq files by using FastQC. Sequencing reads with Phred quality score higher than 30 were further processed for genomic mapping using STAR with parameter chimsegmentMin=20, minimum overhang for spliced alignments =1, and missing values = 0.04. Feature Counts (Subread) were used to count raw reads on each transcript." "Assembly: GRCH38" "Supplementary files format and content: Comma delimited text file for raw read counts" "GPL21697" "chengqi,,wang" "chengqi@usf.edu" "University of South Florida" "4202 E Fowler Ave" "Tampa" "33620" "USA" "0" "NextSeq 550" "cDNA" "transcriptomic" "RNA-Seq" "BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN31988902" "SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX18464658" "NONE" "HMC3 (ATCC CRL-3304)" "microglial cell" "6" "dex vehicle low6"
